Rapid Improvements In Patient-Reported Outcomes With Certolizumab Pegol In Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis And Non-Radiographic Axial Spondyloarthritis- 24-Week Results Of A Phase 3 Double Blind Rando ...
May 1, 2013, 00:00
10.1016/j.jval.2013.03.1150
https://www.valueinhealthjournal.com/article/S1098-3015(13)01221-7/fulltext
Title :
Rapid Improvements In Patient-Reported Outcomes With Certolizumab Pegol In Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis And Non-Radiographic Axial Spondyloarthritis- 24-Week Results Of A Phase 3 Double Blind Rando ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)01221-7&doi=10.1016/j.jval.2013.03.1150
First page :
A227
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
727